Contact Us marketing@medicilon.com
Medicilon Logo
|
search icon search icon 中 contact icon menu icon
Medicilon Logo
|
search icon close search icon 中 contact icon menu icon
ABOUT
Company Profile
Corporate Culture
Management Team
Company History
Message from the CEO
Honors and Awards
Over 20 years of experience in R&D
Learn more
01 Drug Discovery
Chemistry Research
Biology Research
Early Pharmacokinetics
02 Pharmaceutical Research
Intermediates
Active Pharmaceutical Ingredients
Pharmaceutical preparation
Analytical Method Development and Quality Control
CMC Filings
Analytical Testing Center
03 Preclinical Research
Pharmacology & Pharmacodynamics
Drug Safety Evaluation
DMPK
Bioanalysis
IND Filings
01 One-stop Integrated Services
Liposome Drug Development
Drug Discovery
Pharmaceutical Research
Preclinical Research
Botanical Drug Preclinical R&D
02 Innovative Drug Services
ADC
PROTAC
mRNA Vaccine
Cellular Immunotherapies
Nucleic Acid Drug
Peptide Drug Conjugate (PDC)
Antibody
03 Key Technical Services for Drug R&D
Cytokine and Biomarker Detection
Metabolite Identification (MetID)
Drug Forming Research
Flow Cytometry Technology
SEND Format Conversion
Flow Sorting
NanoString nCounter Detection
Routes of Drug Administration
04 Drug Efficacy Evaluation for Common Diseases
IO Pharmacodynamic Model
Inflammatory and Immune Diseases
Rodent Cerebrovascular Disease
05 Advanced Preparation R&D
Inhalation drug
Ophthalmic drug
Skin Topical Preparation
06 Targeted Drugs R&D Services
STAT3-targeted Drugs R&D Service
GLP-1 New Drug R&D Service
KRAS-targeted Drugs R&D Service
CAREERS
Talent Development
Campus Recruitment
Recruitment
Campus Recruitment
Campus Recruitment
Recruitment
Recruitment
News
Medicilon Events
Featured Stories
Market Events
Videos
A.C.E.
2024-07-22Medicilon Events
The Shanghai Overseas Returned Scholars Association invites the Dutch PhD delegation to visit Medicilon, exploring paths for innovative development together
On July 4th, the Shanghai Overseas Returned Scholars Association invited the Dutch PhD delegation to visit the Chuansha campus of Shanghai Medicilon Inc. (Medicilon) and held discussions with Medicilon's Founder and CEO, Chunlin Chen, among others.
Learn more
2024-07-22Medicilon Events
5th consecutive win! Medicilon once again made the list of "Top 20 Chinese R&D CRO Enterprises in 2024"
Medicilon stood out among hundreds of pharmaceutical enterprises and was honored with the "Top 20 Chinese R&D CRO Enterprises in 2024" award.
Learn more
INVESTORS
Stock Information
Investment Contact
Medicilon 688202
RMB

As of Beijing time The data is from a third-party organization and is only for reference.

For actual information, please refer to：www.eastmoney.com

CLIENT CENTER
Intellectual Property Protection
Clients Testimonials
Downloads
Partnerships
Medicilon Support
Newsletters
U.S.

Address: 20 Maguire Road, Suite 103, Lexington, MA 02421(America)

Tel: +1(626)986-9880

UK

Address: Allia Future Business Centre Kings Hedges Road Cambridge CB4 2HY, UK

Tel: 0044 7790 816 954

Email: marketing@medicilon.com

China

Address: No.585 Chuanda Road, Pudong New Area, Shanghai (Headquarters)

Postcode: 201299

Tel: +86 (21) 5859-1500 (main line)

Fax: +86 (21) 5859-6369

Close

© 2023 Shanghai Medicilon Inc. All rights reserved Shanghai ICP No.10216606-3

Shanghai Public Network Security File No. 31011502018888 | Website Map

© 2023 Shanghai Medicilon Inc. All rights reserved Shanghai ICP No.10216606-3
Shanghai Public Network Security File No. 31011502018888|Website Map
关闭
中
Message
Contact Us
Close Button
Back To Top
Online Message×
Click switch
Close Button
Medicilon Events
News and Events
Medicilon Events Featured Stories Market Events Videos A.C.E.
HomenewsMedicilon Events

Medicilon Events

Hot information：
Medicilon Appoints Dr. Liu Jian as President of Drug Discovery Division| Medicilon and Wuhan biolake successfully organized a biopharmaceutical salon| Medicilon FTE services & FFS services - flexible and efficient cooperation model
Nov 22,2021
Within 10 days, three Bispecific Antibody Drugs Assisted by Medicilon were Approved!
On October 19, Bio-Thera's new double-antibody drug BAT7104 was granted implicit approval for clinical trials.
More
Within 10 days, three Bispecific Antibody Drugs Assisted by Medicilon were Approved!
Oct 28,2021
[Medicilon Assist] Bio-Thera's Bispecific Antibody BAT7104 has been Approved for Clinical Trials
​Recently, Bio-Thera's PD-L1/CD47 bispecific antibody BAT7104 injection has been granted implicit permission for clinical trials, and the approved indication is advanced malignant tumors. It is reported that BAT7104 has started overseas clinical research.
More
[Medicilon Assist] Bio-Thera's Bispecific Antibody BAT7104 has been Approved for Clinical Trials
Oct 21,2021
AI Empowers the Development of Innovative Tumor Drugs! Medicilon and MindRank Reached a Strategic Cooperation
On October 21, 2021, Shanghai Medicilon and Hangzhou MindRank signed a strategic agreement in Chuansha Park of Medicilon.
More
AI Empowers the Development of Innovative Tumor Drugs! Medicilon and MindRank Reached a Strategic Cooperation
Oct 21,2021
Medicilon was Awarded The "Golden Horse Award-2021 Best Preclinical CRO/CDMO Enterprise"
From October 19-21, 2021, a grand event that has attracted the attention of the national pharmaceutical industry, "2021 Nanjing International Summit on Innovation and Investment
More
Medicilon was Awarded The "Golden Horse Award-2021 Best Preclinical CRO/CDMO Enterprise"
Oct 21,2021
Medicilon Symposium – "Preclinical Development Strategy of Innovative Drugs Driven by Translational Medicine" was Successfully Held
Shanghai Medicilon Inc. (Medicilon) and the summit organizer jointly held a symposium on PMIO China 2021 with the theme.
More
Medicilon Symposium – "Preclinical Development Strategy of Innovative Drugs Driven by Translational Medicine" was Successfully Held
Oct 18,2021
The Internationalization Trend of Chinese Pharmaceutical Companies and AI R&D Innovation Forum
Two forum themes, an inaugural meeting of Zhangjiang AI New Drug R&D Alliance Establishment, three keynote speeches, three rounds of roundtable discussion, a gathering of
More
The Internationalization Trend of Chinese Pharmaceutical Companies and AI R&D Innovation Forum
Oct 14,2021
Mr. Guolin Wang, Director and Secretary of the Board of Medicilon, won another award!
Recently, the selection of 2021 elite board secretaries of the Cai Lian She (CLS) and the Night of Qingdao Board Secretaries were held in Haitian
More
Mr. Guolin Wang, Director and Secretary of the Board of Medicilon, won another award!
Oct 12,2021
Join Medicilon at the AAPS 2021 PharmSci 360
Medicilon is looking forward to meeting you at this year's American Association of Pharmaceutical Scientists (AAPS) annual meeting—"PharmSci 360″. PharmSci 360 is an in-person meeting + virtual
More
Join Medicilon at the AAPS 2021 PharmSci 360
Oct 11,2021
Introduction to Medicilon's Chemistry and Biology Labs: Preclinical Drug Discovery and Development
https://www.youtube.com/embed/_dGe5Lbvkys
More
Introduction to Medicilon's Chemistry and Biology Labs: Preclinical Drug Discovery and Development
Oct 11,2021
Medicilon's CMC Services: Process and Formulation
Related Articles: The Value and Importance of Preformulation Research
More
Medicilon's CMC Services: Process and Formulation
Oct 11,2021
Video of Medicilon Preclinical Research Services
Related Articles: What is Preclinical Trails? Integrated Preclinical Trails Services New Drug Preclinical Trails
More
Video of Medicilon Preclinical Research Services
Oct 09,2021
Medicilon Won Four Heavyweight Awards in One Fell Swoop!
On September 28, the list of "15th China Listed Company Value Selection", sponsored by Securities Times and specially co-organized by Caitong Securities, was officially announced.
More
Medicilon Won Four Heavyweight Awards in One Fell Swoop!
Stock Code
688202

Global

Address: 20 Maguire Road, Suite 103, Lexington, MA 02421(America)

Tel: +1(626)986-9880(U.S.)

Address: Allia Future Business Centre Kings Hedges Road Cambridge CB4 2HY, UK

Tel: 0044 7790 816 954 (Europe)

Email: marketing@medicilon.com

  

Address: 5th Floor, 62, Banpodae-ro 4-gil, Seocho-gu, Seoul, 06719 South Korea

Tel: +82 70-8269-5849

China

Address: No.585 Chuanda Road, Pudong New Area, Shanghai (Headquarters)

Postcode: 201299

Tel: +86 (21) 5859-1500 (main line)

Fax: +86 (21) 5859-6369

Facebook icon
Twitter icon
Linkedin icon
Youtube icon
© 2023 Shanghai Medicilon Inc. All rights reserved All Rights Reserved Privacy Policy
Website Map
-->